Americas' Drug Markets Remain Attractive

BMI View: The pharmaceutical markets in the Americas' region have retained their status as relatively stable investment destinations in BMI's Q412 Pharmaceutical Risk/Rewarding Ratings (RRRs). Brazil and Mexico have swapped positions within our ratings table, with their rankings indicative of the possibility of fundamental changes in the two markets due to the macroeconomic factors. Regionally, Brazil is the most attractive country for pharmaceutical companies. We also note that the improving regulatory environment offers more opportunities for multinational drugmakers.

To read the full article, please choose one of the following options: